Corxel Pharmaceuticals

Corxel Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for patients with cardiometabolic conditions around the world

corxelbio.com

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

Corxel Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for patients with cardiometabolic conditions around the world.

02Backed By1 investor

SOSR One→

03Recent Activity

Is this your company? Claim your profile

Startup Intelligence by F4F4 Research Engine

FROM SR One

Corxel closed a $287M Series D1 financing to advance its cardiometabolic pipeline including an oral GLP-1 receptor agonist.

INVESTMENT·corxelbio.com

JAN 22, 2026

04Similar Companies

C

CORXEL

Biotech & Life Sciences

→

QL

QroGen Life Sciences

Biotech & Life Sciences

→

NS

NuSirt Sciences

Biotech & Life Sciences

→

SP

Scohia Pharma

Biotech & Life Sciences

→

CT

Caldan Therapeutics

Biotech & Life Sciences

→

05Startup DNA

signals

Sectors
Business Model
Technology

Quick Reference

Sector

Biotech & Life Sciences · Healthcare & Digital Health

Website

corxelbio.com

Visit corxelbio.com ↗